GlassScriptPhysician profile
Amy K Mckerrow
NPI 1376598433
$9,401.38
in general payments reported to CMS, 2019-2025
22 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,866 · 2020: $387 · 2021: $228 · 2022: $62.75 · 2023: $3,907 · 2024: $2,562 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,365 · Food and Beverage: $2,313 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,365.11 |
| Food and Beverage | $2,313.05 |
| Education | $179.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,142.40 | 2019-2024 | Altis, Restorelle |
| Valencia Technologies Corporation | $1,236.85 | 2023-2025 | Ecoin Device Kit |
| Medtronic USA, INC. | $867.27 | 2019 | |
| Astellas Pharma US INC | $553.36 | 2019-2024 | |
| Intuitive Surgical, INC. | $534.44 | 2019-2020 | |
| Medtronic, INC. | $377.64 | 2023-2025 | Interstim |
| Axonics, INC. | $341.08 | 2023 | Axonics |
| Procept Biorobotics Corporation | $313.59 | 2024 | Aquabeam System |
| Janssen Biotech, INC. | $267.16 | 2019-2025 | Rybrevant, Carvykti |
| Abbvie INC. | $202.69 | 2020-2025 | |
| Boston Scientific Corporation | $118.57 | 2019-2025 | Solyx Sis System, Spaceoar Vue System - 10ml |
| Amgen INC. | $96.06 | 2019-2020 | |
| Allergan, INC. | $82.97 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $66.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $53.18 | 2025 | Lynparza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $43.69 | 2019 | |
| Calyxo, INC. | $30.94 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $25.97 | 2019 | |
| Myriad Genetic Laboratories, INC. | $15.83 | 2021 | |
| Innovation Technologies INC | $14.00 | 2019 | |
| Pfizer INC. | $13.43 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mckerrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.